Back to company

Evosep ApS: Financial statements 2017

CVR: 37510068

Evosep ApS (CVR 37510068) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -2,722,228 and a net result of DKK -8,613,473 compared with DKK -4,195,093 the year before. Equity amounted to DKK 7,228,553. The solvency ratio was 75%.

Gross Profit
-2,722,228 kr.
Profit/Loss
-8,613,473 kr.
Equity
7,228,553 kr.
Total Assets
9,631,829 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--2.7 mio.-8.6 mio.7.2 mio.-
2016--1.2 mio.-4.2 mio.7.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Evosep ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

Evosep ApS publishes interim reportApr 24, 2017

Evosep ApS has published its interim report for the period March 1, 2016 – December 31, 2016.

About Evosep ApS

Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees. In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity amounted to DKK 154,548,000.